Moreover, we demonstrated that TRIAP1 overexpression was associated with poor survival and was an independent risk factor in NPC, indicating a significant therapeutic implication of TRIAP1 in NPC. The gene discussed is TRIAP1; the disease is nasopharyngeal carcinoma.